Data from Multiple Myeloma Research Foundation (MMRF) research programs fuel advances presented at the 65th American Society of Hematology Annual Meeting
December 7, 2023
View
Multiple Myeloma Research Foundation (MMRF) Announces First Recipients of Scholars Program Awards, a Critical Step in Improving Diversity and Inclusion in Multiple Myeloma Research
November 30, 2023
Updates in MM From IMS 2023 for Health Care Professionals—Part 3
November 17, 2023
Updates in MM From IMS 2023 for Health Care Professionals—Part 2
Updates in MM From IMS 2023 for Health Care Professionals —Part 1
Myeloma Investment Fund Invests in Reverb Therapeutics to Support Debut of its Amplifier™ Platform for Redirecting Endogenous Cytokines
November 15, 2023
Interesting Take-Aways from our Bispecific Antibodies Webinar
November 10, 2023
2023 Accelerator
November 8, 2023
The Multiple Myeloma Research Foundation Announces $21M Grant Program to Support Multicenter Translational Research Networks
November 2, 2023
Answers to FAQs from our 10/11/23 webinar on non-BCMA-Targeted Bispecific Antibodies
October 16, 2023
The Multiple Myeloma Research Foundation (MMRF) Names Stephanie Oestreich, Ph.D., MPA, as Managing Director of the Myeloma Investment Fund (MIF)
October 5, 2023
Day 3 Highlights from the 20th International Myeloma Society Annual Meeting
October 2, 2023
Knowledge is power. Sign up today and we’ll help you stay informed.
sign up
We value your privacy.
